Regulatory Exclusivity: NEW CHEMICAL ENTITY
✉ Email this page to a colleague
Drugs with New Chemical Entity Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|
| Abbvie | DALVANCE | dalbavancin hydrochloride | 021883 | May 23, 2014 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | NEW CHEMICAL ENTITY |
| Abbvie | DALVANCE | dalbavancin hydrochloride | 021883 | May 23, 2014 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | NEW CHEMICAL ENTITY |
| Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | 205435 | Jun 20, 2014 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | NEW CHEMICAL ENTITY |
| Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | 205435 | Jun 20, 2014 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | NEW CHEMICAL ENTITY |
| Cubist Pharms Llc | SIVEXTRO | tedizolid phosphate | 205435 | Jun 20, 2014 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | NEW CHEMICAL ENTITY |
| >Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |
